Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider Sells 9,922 Shares

Key Points

• Integral Ad Science CEO Lisa Utzschneider sold 9,922 shares at an average price of $8.12, totaling approximately $80,566, which represents a 2.54% decrease in her ownership position.
• The company's stock is currently trading at $8.89, with a 1-year low of $6.26 and a high of $13.62, indicating significant volatility in its market performance.
• Integral Ad Science reported earnings of $0.07 per share for the last quarter, surpassing expectations, with revenue of $149.20 million compared to estimates of $143.02 million.

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CEO Lisa Utzschneider sold 9,922 shares of the stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $8.12, for a total value of $80,566.64. Following the completion of the transaction, the chief executive officer owned 380,557 shares of the company's stock, valued at $3,090,122.84. This trade represents a 2.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Lisa Utzschneider also recently made the following trade(s):

• On Thursday, July 10th, Lisa Utzschneider sold 8,285 shares of Integral Ad Science stock. The shares were sold at an average price of $8.29, for a total value of $68,682.65.
• On Tuesday, July 8th, Lisa Utzschneider sold 14,904 shares of Integral Ad Science stock. The shares were sold at an average price of $8.31, for a total value of $123,852.24.

Integral Ad Science Stock Performance

Shares of NASDAQ:IAS traded down $0.03 during trading on Tuesday, hitting $8.89. 1,330,282 shares of the stock were exchanged, compared to its average volume of 1,036,400. Integral Ad Science Holding Corp. has a 1-year low of $6.26 and a 1-year high of $13.62. The company has a market capitalization of $1.48 billion, a price-to-earnings ratio of 26.15, a price-to-earnings-growth ratio of 1.41 and a beta of 1.57. The company's fifty day simple moving average is $8.22 and its 200-day simple moving average is $8.50.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.03. Integral Ad Science had a return on equity of 5.00% and a net margin of 9.79%. The company had revenue of $149.20 million for the quarter, compared to analyst estimates of $143.02 million. On average, research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Institutional Trading of Integral Ad Science

Several institutional investors have recently modified their holdings of IAS. Alyeska Investment Group L.P. bought a new position in Integral Ad Science in the 4th quarter valued at $41,543,000. Corvex Management LP bought a new stake in shares of Integral Ad Science during the first quarter worth $21,101,000. Nuveen LLC acquired a new stake in shares of Integral Ad Science during the first quarter worth $10,897,000. Alta Fox Capital Management LLC grew its stake in shares of Integral Ad Science by 20,831.9% during the first quarter. Alta Fox Capital Management LLC now owns 1,214,053 shares of the company's stock worth $9,785,000 after purchasing an additional 1,208,253 shares during the period. Finally, CenterBook Partners LP grew its stake in shares of Integral Ad Science by 163.3% during the second quarter. CenterBook Partners LP now owns 1,716,602 shares of the company's stock worth $14,265,000 after purchasing an additional 1,064,722 shares during the period. Institutional investors and hedge funds own 95.78% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on IAS. Wall Street Zen raised Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Sunday. Morgan Stanley reduced their price objective on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Stifel Nicolaus increased their price objective on Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Raymond James Financial reduced their price objective on Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating for the company in a research note on Friday. Finally, Barclays increased their price objective on Integral Ad Science from $9.00 to $10.00 and gave the stock an "equal weight" rating in a research note on Friday. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Integral Ad Science has an average rating of "Moderate Buy" and an average price target of $13.55.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.